Global D-Amino Acid Market Analysis & Trends - Industry Forecast to 2030
D-Amino Acid: Market Size
From $270.78 million in 2024, the global D-Amino Acid market is projected to reach $449.15 million by 2030. Based on our analysis the market is expected to grow at a CAGR of 8.8% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include, rapid expansion of the healthcare sector, increasing demand from end use industries and increasing awareness about health and changing lifestyle.
Global D-Amino Acid Market: Market Dynamics
The D-Amino Acids market has witnessed significant growth owing to factors diversification of application base across various industries. It is also used as a sweetener in food and beverages. Its multifarious applications across various industries also contribute to the growth of the market. D-amino acids find their usage as cosmetic agents and as therapeutic agents for skin moisturizers. Continuous research and development to bring down the cost of production of the acid through the adoption of advanced technologies is a key trend witnessed in the D-amino acid market.
For instance, in August 2022, the Technical University of Munich developed a novel enzymatic process for the production of a variety of essential amino acids that are used in food supplements.
On the other hand, the increasing peptide enzymatic stability, enhance the activity and selectivity of antimicrobial peptides, and also helps in the early detection of Alzheimer's disease will further boost the market.
Impact of COVID-19 on D-Amino Acid
The outbreak of COVID-19 has a moderate impact on the D-amino acid market. COVID-19 is at high risk in patients with obesity, as they have less immunity. D-amino acid is very significant in the human body as most of the vital processes of the human body such as immune function, tissue growth, energy production, and nutrient absorption are carried out with the help of it. Though COVID-19 has adversely affected the global D-amino acid market. But, owing to quarantine, travel restriction has greatly affected the supply of the D-amino acid market across the globe. Covid-19 may not negatively impact the market growth as the pharmaceutical sector is open in full force in the lockdown period also.
By End User
Pharmaceuticals Segment Dominate the Market in 2024
The pharmaceuticals segment made huge revenue in 2024 and growing its prominence during the forecast period. D-amino acids are mainly employed in physiological and medical applications such as neurotransmission and hormonal regulation. These D-amino based peptides possess producing characteristics and are used in the treatment of Alzheimer's disease and tumors. Demand for the usage of peptides in pharmaceutical applications is anticipated to enhance the requirement of D-amino acid. Nearly 70% of the pharmaceutical products are chiral molecules of various compounds, including amino acids. Having become important chiral-building components for various pharmaceuticals and over 3 thousand amino acid derivatives, D-amino acids represent high-value intermediates in the pharmaceutical sector and find several applications in this area.
By Geography
Asia Pacific Region is Leading in the Global Market Place
Asia Pacific is likely to have a huge demand in the forecast period owing to the presence of a large number of manufacturers and processors in the pharmaceutical industry. Rapid industrialization and expansion of pharmaceutical manufacturing and processing plants in the developed countries such as China and Japan are projected to boost the demand for D-amino acid in these countries.
List of the Key Players profiled in the market Include: • AnaSpec, Inc
• Central Drug House (P) Ltd
• Daesang Corporation
• Evonik Industries AG
• Kyowa Hakkon Kirin Co. Ltd
• Prinova Group LLC
• Sekisui Medical Co. Ltd
• Shanghai Brightol International
• Shijiazhuang Haitian Amino Acid
• Sichuan Tongsheng Amino acid Co., Ltd
• Tokyo Chemical Industry Co., Ltd
• Varsal Chemicals
• Wuhan Amino Acid Bio-Chemical
• Yoneyama Yakuhin Kogyo Co., Ltd
• Zhangjiagang Huachang Pharmaceutical Co. Ltd
List of the regions/countries profiled in the market Include: North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others